SG11201708214UA - Combination of at least one protease inhibitor and at least one active principle for use in the prevention and/or treatment of skin lesions - Google Patents

Combination of at least one protease inhibitor and at least one active principle for use in the prevention and/or treatment of skin lesions

Info

Publication number
SG11201708214UA
SG11201708214UA SG11201708214UA SG11201708214UA SG11201708214UA SG 11201708214U A SG11201708214U A SG 11201708214UA SG 11201708214U A SG11201708214U A SG 11201708214UA SG 11201708214U A SG11201708214U A SG 11201708214UA SG 11201708214U A SG11201708214U A SG 11201708214UA
Authority
SG
Singapore
Prior art keywords
prevention
treatment
combination
protease inhibitor
active principle
Prior art date
Application number
SG11201708214UA
Inventor
Alessandro Assandri
Original Assignee
Eurodrug Laboratories B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurodrug Laboratories B V filed Critical Eurodrug Laboratories B V
Publication of SG11201708214UA publication Critical patent/SG11201708214UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/56—Protease inhibitors from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SG11201708214UA 2015-04-17 2015-04-17 Combination of at least one protease inhibitor and at least one active principle for use in the prevention and/or treatment of skin lesions SG11201708214UA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2015/058451 WO2016165783A1 (en) 2015-04-17 2015-04-17 Combination of at least one protease inhibitor and at least one active principle for use in the prevention and/or treatment of skin lesions

Publications (1)

Publication Number Publication Date
SG11201708214UA true SG11201708214UA (en) 2017-11-29

Family

ID=52988064

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201708214UA SG11201708214UA (en) 2015-04-17 2015-04-17 Combination of at least one protease inhibitor and at least one active principle for use in the prevention and/or treatment of skin lesions

Country Status (18)

Country Link
EP (1) EP3283093B1 (en)
KR (1) KR102359285B1 (en)
CN (1) CN107683144B (en)
AR (1) AR104265A1 (en)
BR (1) BR112017022286A2 (en)
CO (1) CO2017010543A2 (en)
DK (1) DK3283093T3 (en)
ES (1) ES2830379T3 (en)
HK (1) HK1246205A1 (en)
HR (1) HRP20201777T1 (en)
HU (1) HUE052035T2 (en)
MX (1) MX2017013352A (en)
MY (1) MY196133A (en)
PH (1) PH12017501889A1 (en)
PT (1) PT3283093T (en)
RS (1) RS61576B1 (en)
SG (1) SG11201708214UA (en)
WO (1) WO2016165783A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112402273B (en) * 2020-12-01 2023-10-03 金发拉比妇婴童用品股份有限公司 Cream for improving red buttocks of infants and preparation method of cream

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200002601T2 (en) * 1998-03-12 2000-12-21 The Procter & Gamble Company Disposable absorbent article having a skin care composition containing an enzyme inhibitor.
EP0958833A1 (en) * 1998-05-20 1999-11-24 Erasmus Universiteit Rotterdam Methods and means for preventing or treating inflammation
US6207596B1 (en) * 1998-11-09 2001-03-27 The Procter & Gamble Company Disposable premoistened wipe containing an antimicrobial protease inhibitor
US7005557B2 (en) * 2001-07-03 2006-02-28 The Procter & Gamble Company Film-forming compositions for protecting skin from body fluids and articles made therefrom
US20050175719A1 (en) * 2004-02-05 2005-08-11 Ying Sun Procyanidins for treatment and prevention of enzymatic irritation to the skin
EP1586336A1 (en) * 2004-04-06 2005-10-19 JOHNSON & JOHNSON GmbH Compositions containing copper salts and soy products
NZ547991A (en) * 2005-06-22 2008-08-29 Bristol Myers Squibb Co Enzyme inhibiting sprayable skin barrier compositions comprising enzyme inhibitors derived from potatoes

Also Published As

Publication number Publication date
EP3283093B1 (en) 2020-09-16
HUE052035T2 (en) 2021-04-28
MY196133A (en) 2023-03-16
MX2017013352A (en) 2018-06-22
RS61576B1 (en) 2021-04-29
KR20180003553A (en) 2018-01-09
WO2016165783A1 (en) 2016-10-20
DK3283093T3 (en) 2020-11-09
AR104265A1 (en) 2017-07-05
CO2017010543A2 (en) 2018-03-09
BR112017022286A2 (en) 2018-07-10
CN107683144A (en) 2018-02-09
HK1246205A1 (en) 2018-09-07
ES2830379T3 (en) 2021-06-03
KR102359285B1 (en) 2022-02-07
CN107683144B (en) 2020-08-07
EP3283093A1 (en) 2018-02-21
PT3283093T (en) 2020-11-03
PH12017501889A1 (en) 2018-03-05
HRP20201777T1 (en) 2021-01-08

Similar Documents

Publication Publication Date Title
GB201411496D0 (en) Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy
ZA201704726B (en) Peptides and their use in the treatment of skin
IL251351A0 (en) Compositions for use in the treatment and prophylaxis of surgical site infections
HK1257585A1 (en) Medicine for preventing and treating skin fibrosis and use of the medicine
EP3541185C0 (en) Use of 2-hydroxybenzylamine in the treatment and prevention of pulmonary hypertension
MX2015013755A (en) Pharmaceutical formulation for use in the treatment and/or prevention of restenosis.
IL261834A (en) Cd31shed agonists for use in the prevention and/or treatment of reperfusion injury
EP3065548A4 (en) Fibrosis inhibiting compounds and methods of use thereof in the prevention or treatment of fibrosing diseases
HK1246205A1 (en) Combination of at least one protease inhibitor and at least one active principle for use in the prevention and/or treatment of skin lesions
IL259383A (en) Compound for use in the prevention and treatment of neurodegenerative diseases
HK1252359A1 (en) Combination of trazodone and gabapentin for the treatment of pain
HUE066497T2 (en) The use of guaiacol for the prevention and treatment of glycogen storage disease
IL273863B1 (en) Device for use in the treatment of hemorrhoids
PT3191112T (en) Dipeptidyl ketoamide compounds and their use for the treatment and/or prevention of fat accumulation
PT2862576T (en) Microorganisms and compositions comprising them for use in the treatment or prevention of mastitis
SG11201802955VA (en) Peptides of use in the preventive and curative treatment of alopecia
HUE043237T2 (en) Synergistic composition comprising propolis and carnosic acid for use in the prevention and treatment of candidiasis
GEP20197038B (en) Combination of at least one protease inhibitor and at least one active principle for use in the prevention and/or treatment of skin lesions
HK1251178A1 (en) Clonidine and/or clonidine derivatives for use in the prevention of skin injury resulting from radiotherapy
IL261240B (en) Compositions useful in the prevention and/or treatment of inflammation and pain
HK1219880A1 (en) Use of oxygen-enriched water in manufacture of medicament for treatment and or prevention of hyperuricemia
PT3268378T (en) Galactolipid for use thereof in healing and in prevention and/or treatment of skin ageing